Results for tag: "Prolastin C"

Prolastin C is a respiratory drug used to treat alpha-1 antitrypsin deficiency, a genetic disorder that can cause lung and liver damage. It is a recombinant form of alpha-1 antitrypsin, a protein that helps protect the lungs from damage caused by inflammation. Prolastin C is administered intravenously and is approved for use in adults and children. It is the only approved therapy for alpha-1 antitrypsin deficiency in the United States. The Prolastin C market is highly competitive, with several companies offering similar products. Companies in the market include Grifols, CSL Behring, Baxter, and Octapharma. These companies are engaged in research and development of new products, as well as marketing and distribution of existing products. They are also involved in clinical trials to evaluate the safety and efficacy of Prolastin C. Show Less Read more